Healthcare / Medical Care FacilitiesSES
$0.95
-0.01 (-1.55%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $91.3M · quality 77.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.7B
P/E
23.8x
↑EV/EBITDA
10.7x
↓ROE
6.7%
↑Gross Margin
65.0%
↑Debt/Equity
0.08
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.4%
FCF CAGR
-18.9%
FCF margin
11.9%
FCF / Net income
1.29x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $765.3M · net income $70.6M · FCF $91.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $765.3M | $765.3M | $751.6M | $706.9M | $822.9M |
| Net Income | $70.6M | $70.6M | $62.2M | $90.2M | $143.2M |
| EBITDA | $142.2M | $142.2M | $135.8M | $163.8M | $238.4M |
| EPS | — | — | 0.03 | 0.05 | 0.08 |
| Gross Margin | 65.0% | 65.0% | 64.7% | 67.8% | 76.2% |
| Operating Margin | 11.7% | 11.7% | 11.5% | 16.4% | 26.0% |
| Net Margin | 9.2% | 9.2% | 8.3% | 12.8% | 17.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.08 | 0.08 | 0.08 | 0.11 | 0.09 |
| Current Ratio | 1.31 | 1.31 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $91.3M | $91.3M | $65.3M | $167.4M | $170.9M |
| Returns | |||||
| ROE | 6.7% | 6.7% | 5.9% | 8.8% | 14.1% |
| Valuation | |||||
| P/E | 23.75 | 23.75 | 24.85 | 21.99 | 18.51 |
| EV/EBITDA | 10.72 | 10.72 | 9.49 | 10.66 | 10.46 |
| P/B | 1.65 | 1.65 | 1.47 | 1.93 | 2.62 |
| Growth & Yield | |||||
| Revenue Growth | 1.8% | 1.8% | 6.3% | -14.1% | — |
| EPS Growth | — | — | -30.7% | -37.2% | — |
| Dividend Yield | 3.1% | 3.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
n/dx → n/dx
EPS bridge
0.03 → n/d
Residual
-3.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.